Sanibel Captiva Trust Company’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$456K Hold
6,700
0.01% 320
2025
Q4
$509K Hold
6,700
0.01% 297
2025
Q3
$411K Hold
6,700
0.01% 321
2025
Q2
$327K Hold
6,700
0.01% 338
2025
Q1
$341K Hold
6,700
0.01% 318
2024
Q4
$302K Hold
6,700
0.01% 334
2024
Q3
$249K Hold
6,700
0.01% 352
2024
Q2
$205K Buy
+6,700
New +$217K 0.01% 353

Other funds holding PTCT

Sanibel Captiva Trust Company's PTCT Position: Q1 2026 in Review

Sanibel Captiva Trust Company held its PTC Therapeutics (PTCT) position steady in Q1 2026 at 6,700 shares worth $456K. The position accounts for 0.01% of the portfolio, ranked #320.

Sanibel Captiva Trust Company first reported a position in PTCT in Q2 2024 and has held it in 8 quarters since. The position peaked at $509K in Q4 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Sanibel Captiva Trust Company held 6,700 shares of PTC Therapeutics worth $456K as of Q1 2026.
  • Sanibel Captiva Trust Company left its PTC Therapeutics share count unchanged in Q1 2026.
  • PTC Therapeutics made up 0.01% of Sanibel Captiva Trust Company's portfolio in Q1 2026, its #320 holding.
  • Sanibel Captiva Trust Company first reported a position in PTC Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Sanibel Captiva Trust Company's PTC Therapeutics position peaked at $509K in Q4 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q1 2026, filed 15 May 2026.